In the dynamic landscape of global investments, H.I.G. Capital stands out for its strategic maneuvers within the healthcare and adjacent sectors. Leveraging its expertise, the Miami-based firm with $65 billion under management has recently amplified its market presence through calculated acquisitions.

One of H.I.G. Capital’s significant moves was the acquisition of SkinCure Oncology. This Illinois-based company specializes in image-guided superficial radiation therapy, a less invasive treatment for nonmelanoma skin cancer. By partnering with over 500 physicians and treating more than 100,000 patients, SkinCure Oncology has established itself as a leader in non-invasive cancer therapies. This acquisition marks a noteworthy expansion of H.I.G. Capital’s healthcare portfolio.

In addition to healthcare, the firm has shown interest in other sectors, evidenced by its acquisition of Action Elevator. This company provides essential services such as maintenance and modernization of elevators, serving clients across various industries, including healthcare. This move highlights H.I.G. Capital’s strategy to invest in infrastructure services that complement and support healthcare facilities.

Moreover, H.I.G. Capital broadened its reach into the organic market by acquiring a majority stake in Naturalia Tantum S.p.A., an Italian producer of natural beauty and personal care products. This acquisition aligns with the firm’s interest in tapping into the growing demand for organic and natural consumer products.

Meanwhile, H.I.G. Capital recently made headlines with the sale of BIOVECTRA, a contract development and manufacturing organization, to Agilent Technologies, Inc. The transaction not only underscores the firm’s ability to develop and divest successful enterprises but also exemplifies its adeptness in navigating the pharmaceutical manufacturing landscape.

With these strategic moves, H.I.G. Capital continues to position itself as a formidable player, capitalizing on diverse growth opportunities across multiple sectors.